Related Experiment Video

Updated: Feb 6, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.4K

Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug

Wei Song1, Meilin Liu1, Junjun Wu2

  • 1School of Life Sciences, Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei University, Wuhan 430062, China.

Current Drug Metabolism
|August 17, 2018
PubMed
Abstract

Insights

Triptolide shows potent anticancer activity but has toxicity issues. Understanding its pharmacokinetics, including absorption, distribution, metabolism, and interactions, is crucial for safe clinical use.

Area of Science:

  • Pharmacology and Toxicology
  • Natural Products Chemistry
  • Drug Metabolism and Pharmacokinetics

Background:

  • Triptolide, derived from Tripterygium wilfordii, exhibits broad-spectrum antiproliferative activity against NCI cancer cell lines.
  • Clinical application of triptolide is hindered by multi-organ toxicity and a narrow therapeutic window, linked to its pharmacokinetic profile.
  • Understanding triptolide's distribution and accumulation in target organs is key to mitigating its toxic effects.

Purpose of the Study:

  • To review and synthesize the existing literature on the pharmacokinetics of triptolide.
  • To elucidate the absorption, distribution, metabolism, excretion, and drug-drug interaction profiles of triptolide.
  • To provide insights into how pharmacokinetic properties influence triptolide's efficacy and toxicity.

Main Methods:

  • A comprehensive literature search was conducted across PubMed, SciFinder, and Google Scholar databases.
  • Keywords included 'triptolide', 'pharmacokinetics', 'drug-drug interaction', 'transporters', 'metabolism', and 'modification'.
  • Full-length articles and abstracts published between 2000 and 2018 were collected and analyzed.

Main Results:

  • Oral triptolide is rapidly absorbed, with significant increases in AUC and Cmax when co-administered with grapefruit juice.
  • Triptolide distributes to major organs including the liver, heart, spleen, lungs, and kidneys.
  • Metabolism involves hydroxylation and conjugation (sulfate, glucuronide, NAC, GSH); it is a substrate for P-glycoprotein (P-gp) and CYP3A4, indicating potential for drug interactions.

Conclusions:

  • Pharmacokinetic characteristics are fundamental to understanding triptolide's pharmacological actions and toxicological profile.
  • Knowledge of triptolide's interactions with transporters and metabolic enzymes is essential for optimizing its therapeutic use.
  • Further research into triptolide pharmacokinetics can guide the development of safer and more effective therapeutic strategies.
Keywords:
Triptolideantitumordrug-drug interactionmetabolismpharmacokineticstoxicity.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.7K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.4K

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
451
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
255
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
711